Company Overview and News

 
Wabtec (WAB) Wabtec and GE Transportation to Merge (Transcript)

28m seekingalpha
Good morning, my name is Regina and I’ll be your conference operator today. At this time, I’d like to welcome everyone to the Wabtec and GE Transportation merger conference call. All lines have been placed on mute to prevent any background noise. After the speakers remarks there will be a question and answer session. [Operator Instructions]

 
7 High-Yield ETFs to Help You Diversify Your Basket

3h investorplace
The hunt for yield never ends. Even though interest rates are rising, investors are hunting for different types of securities that throw off income. The good news is that there are high-yielding securities out there, and you don’t have to get too aggressive to find them.

 
IHS Markit's (INFO) CEO Lance Uggla on Acquisition of Ipreo and Intent to Divest MarkitSERV Conference (Transcript)

4h seekingalpha
IHS Markit Ltd (NASDAQ:INFO) Acquisition of Ipreo and Intent to Divest MarkitSERV Conference May 21, 2017 8:00 AM ET

 
Nordson's (NDSN) CEO Mike Hilton on Q2 2018 Results - Earnings Call Transcript

7h seekingalpha
Good day ladies and gentlemen, and welcome to Nordson Corporation Webcast for Second Quarter Fiscal Year 2018. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions for how to participate will follow at that time. [Operator Instructions] As a reminder, this conference call is being recorded.

 
Advance Auto Parts' (AAP) CEO Tom Greco on Q1 2018 Results - Earnings Call Transcript

7h seekingalpha
Advance Auto Parts, Inc. (NYSE:AAP) Q1 2018 Earnings Conference Call May 22, 2018 8:00 AM ET

 
Wells Fargo to boost auto loans

9h bworldonline
WELLS FARGO & Co. Chief Executive Officer Tim Sloan said the firm is ready to increase lending for car sales after pulling back last year, and it’s now looking with consternation at the commercial real estate market.

 
Wall Street Sees Upside of More than 17% for JNJ in the Next Year

10h marketrealist
Over the last few quarters, Johnson & Johnson (JNJ) has seen a number of factors affecting investor sentiments surrounding its stock. The company has witnessed a number of litigations related to its baby care products, a loss of patent for its blockbuster drug Remicade, and the effects of macroeconomic factors, such as pricing pressures, in the US pharmaceuticals industry.

 
Wells Fargo to Focus on Auto Lending, CRE Raises Concern

10h zacks
Per a Bloomberg article, Wells Fargo & Company (WFC - Free Report) plans to boost auto lending business as CEO Tim Sloan finds the commercial real estate (CRE) unit to be a concern.

 
Wells Fargo Could Be In For Years Of Restructuring Pain

20h seekingalpha
Since the Federal Reserve's consent order restricting Wells Fargo growth until it has cleaned up its risk management, the stock has remained relatively stunted.

 
Pure Storage's (PSTG) CEO Charlie Giancarlo on Q1 2019 Results - Earnings Call Transcript

23h seekingalpha
Good afternoon. My name is Chris and I will be your conference operator today. At this time, I would like to welcome everyone to the Pure Storage Q1 Fiscal 2019 Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers’ remarks, there will be a question-and-answer session. [Operator Instructions]

 
Banks Adopt Military-Style Tactics to Fight Cybercrime - The New York Times

23h nytimes
O’FALLON, Mo. — In a windowless bunker here, a wall of monitors tracked incoming attacks — 267,322 in the last 24 hours, according to one hovering dial, or about three every second — as a dozen analysts stared at screens filled with snippets of computer code.

 
Eisman Of 'Big Short' Says 'Deutsche Bank Is A Problem Bank'

2018-05-21 valuewalk
Steven Eisman discusses the U.S. financial system and regulation and why he liks some banks and likes shorting others. He speaks with Yvonne Man from the CFA Annual Conference on “Bloomberg Markets.” Below is the video as well as an informal transcript of part of the talk

 
ValueAct Capital's Investment In Citigroup And Envira Partners

2018-05-21 valuewalk
This week, ValueAct Capital Partners was reported to have made two new investments – one hiking from $70 million to $1.2 billion its stake in global bank Citigroup, market capitalization $183 billion, the other a new position in $778 million wood pellet producer Enviva Partners.

 
Biggest banks prefer full Volcker Rule repeal, but a rewrite would do - MarketWatch

2018-05-21 marketwatch
Rule means traders need ‘a lawyer and a psychiatrist’ beside them to determine intent, says J.P. Morgan CEO Jamie Dimon

 
Wells Fargo: Value And Longevity

2018-05-21 seekingalpha
Wells Fargo (NYSE:WFC) has faced a slew of issues over the past couple of years that have been problematic and detrimental to the company. From opening an abundance of fake customer accounts, to their most recent scandal of charging customers for unnecessary auto insurance and fees for lower mortgage interest rates, Wells Fargo has damaged their reputation and been slapped with $1.185B in fines since 2016.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...

CUSIP: 949746952